Skip to main content
. 2015 Jan 7;6(1):64–69. doi: 10.1111/1759-7714.12133

Table 2.

Changes of HR, HER-2 and Ki-67 status between NAC and control groups [%(n)]

Group NAC (n = 79) Control (n = 82) X2 P value
ER 12.7 (10/79) 2.4 (2/82) 6.092 P = 0.014
PR 24 (19/79) 4.9 (4/82) 12.079 P = 0.001
HER-2 5 (4/79) 2.4 (2/82) 0.772 P = 0.379
Ki-67 38.0 (30/79) 7.3 (6/82) 21.784 P < 0.001

ER, estrogen receptor; HER-2, human epidermal growth factor receptor-2; HR, hormone receptor; NAC, neoadjuvant chemotherapy; PR, progesterone receptor.